Biobanking Market

Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User - Global Forecast to 2028

Report Code: BT 1224 May, 2023, by marketsandmarkets.com

The global biobanking market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by the growing investments and funding for biobanks, focus on genetic testing and precision medicine, increasing trend in the preservation of cord blood stem cells from newborns, and favorable funding scenario for research related to regenerative medicine. On the other hand, the high cost of automated equipment and issues related to biospecimen sample management are restraining the growth of this market.

Biobanking Market- Global Forecast To 2028

Biobanking Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Biobanking Market

Biobanking Market

Biobanking Market Dynamics

DRIVER: Growing investments and funding for biobanks

Biobanks have gained significant recognition from governments, research organizations, and funding agencies worldwide, resulting in a rise in investments in biobanks. For example, the Biorepository and Precision Medicine Initiative (PMI) Cohort Program, funded by the US National Institutes of Health (NIH), aims to collect biological samples from one million or more individuals to create a national research resource. Similarly, the European Commission has invested in the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European infrastructure for biobanking and biomolecular resources.

RESTRAINT: High cost of automated equipment

The high cost of automated equipment is expected to restrain the growth of the market. Automated equipment, such as advanced sample handling systems, can significantly improve the efficiency and quality of biobanking operations. However, the high cost of this equipment can be a significant barrier to the entry of smaller biobanking companies or those with limited financial resources. For instance, the cost of an automated storage system can vary depending on the size and complexity of the system. The initial investment in an automated storage system can be significant, with costs ranging from tens of thousands to hundreds of thousands of dollars. In addition to the initial investment, there are ongoing maintenance and operational costs that must be considered, such as software updates, repairs, and training.

OPPORTUNITY: Emerging countries to provide lucrative opportunities

Developing countries are expected to offer significant growth opportunities for players operating in the global market due to the low-cost manufacturing advantage offered by these countries, coupled with the availability of skilled resources at lower costs. Moreover, as compared to developed markets, such as the US, Germany, and Japan, the demand for medical products in emerging Asian markets, such as China and India, is growing at a robust rate. This has prompted medical product companies to focus on these countries for future growth.

CHALLENGE: High operational cost of biobanks

Due to the increasing utilization of biospecimens for research and the emergence of new technologies, there is a growing focus on the availability and quality of biospecimens and their effective collection. However, the long-term economic situation of biobanks is still mostly unclear, which raises questions regarding their overall sustainability. Several costs add up in the complete functioning of a biobank, including in-case collection, tissue processing, storage management, sample distribution, and infrastructure and administration costs. Additionally, high investments are required to set up the required infrastructure in biobanks. For instance, the cost of installing laboratory facility infrastructure, liquid nitrogen supplies, mechanical freezers, and software systems add to the overall operating costs. Since biobanks have to store samples over a period of time, there is a significant need to optimize operations and costs for their long-term sustainability

The equipment segment dominated biobanking market by product & service:

The equipment segment held the largest share of the global market in 2022. This is primarily attributed to the increasing number of biobanks and biosamples, due to which the demand for equipment remains high. The biobanking equipment segment encompasses a range of specialized products essential for the processing, analysis, storage, and transport of biological samples. These specimens may include human tissues, cells, blood, DNA, and other biospecimens collected from patients, donors, or research participants. The segment covers a broad spectrum of solutions and technologies catering to the diverse needs of biobanks, research institutes, and medical facilities.

Biobanking Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Asia Pacific region of the global biobanking market, is estimated to register the highest CAGR during the forecast period.

The market in the Asia Pacific region has experienced significant growth over the past few years. This growth can be attributed to several factors, such as the increasing prevalence of chronic diseases, rising investments in research and development activities, and the expanding healthcare infrastructure. For instance, countries like China, Japan, and South Korea have witnessed a surge in biobanks and research initiatives aimed at understanding the genetic basis of diseases and developing personalized medicine. These countries have made substantial investments in biobanking infrastructure, including the establishment of state-of-the-art biorepositories and the implementation of stringent quality control measures.

Key players in the biobanking market include Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US).

Biobanking Market Report Scope

Report Metric 

Details 

Market Revenue in 2023

$2.9 billion

Projected Revenue by 2028

$5.0 billion

Revenue Rate

Poised to Grow at a CAGR of 11.4%

Market Driver

Growing investments and funding for biobanks

Market Opportunity

Emerging countries to provide lucrative opportunities

This report categorizes the biobanking market to forecast revenue and analyze trends in each of the following submarkets:

By Product &Service

  • Equipment
    • Storage Equipment
    • Sample Analysis Equipment
    • Sample Processing Equipment
    • Sample Transport Equipment
  • Consumables
    • Storage Consumables
    • Analysis Consumables
    • Processing Consumables
    • Collection Consumables
  • Services
    • Storage Services
    • Processing Services
    • Transport Services
    • Supply Services
  • Software

By Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Biological Fluids
  • Human Waste Products

By Storage Type

  • Manual Storage
  • Automated Storage

By Ownership

  • Universities
  • National/Regional Agencies
  • Non-Profit Organizations
  • Private Organizations

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

By End user

  • Pharmaceutical & Biotechnology Companies and CROs
  • Academic & Research Institutes
  • Hospitals

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
    • Brazil
    • RoLATAM
  • Middle East and Africa (MEA)

Recent Developments

  • In February 2023, PHC Corporation of North America launched the PHCbi Brand VIP ECO SMART Ultra-low Temperature Freezer with industry-leading energy efficiency.
  • In September 2022, Cryoport entered into a strategic partnership with BioLife Plasma Services to offer supply chain solutions and service offerings, such as bioservices and cryo-processing, for BioLife Plasma Services.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 29)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 RESEARCH LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 IMPACT OF ECONOMIC RECESSION
 
2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of primaries
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 2 BIOBANKING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
          FIGURE 3 MARKET SIZE ESTIMATION - COMPANY REVENUE ANALYSIS (2022)
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 4 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 5 MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
          FIGURE 6 MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 IMPACT OF RECESSION ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024−2027
    2.7 RISK ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 8 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    FIGURE 9 MARKET, BY STORAGE TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 MARKET, BY SAMPLE TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 MARKET, BY OWNERSHIP, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 51)
    4.1 BIOBANKING MARKET OVERVIEW 
          FIGURE 15 GROWING INVESTMENTS AND FUNDING FOR BIOBANKS TO DRIVE MARKET
    4.2 NORTH AMERICA: MARKET, BY STORAGE TYPE AND COUNTRY (2022) 
          FIGURE 16 MANUAL STORAGE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 MARKET SHARE, BY APPLICATION, 2023 VS. 2028 
          FIGURE 17 REGENERATIVE MEDICINE SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028
    4.4 MARKET SHARE, BY END USER (2023) 
          FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 54)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 2 MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing investments and funding for biobanks
                    5.2.1.2 Focus on genetic testing and precision medicine
                    5.2.1.3 Increasing trend in preservation of cord blood stem cells from newborns
                    5.2.1.4 Favorable funding scenario for research related to regenerative medicine
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of automated equipment
                    5.2.2.2 Issues related to biospecimen sample management
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies to provide lucrative opportunities
           5.2.4 CHALLENGES
                    5.2.4.1 High operational cost of biobanks
                    5.2.4.2 Storage of samples
    5.3 RANGES/SCENARIOS 
          FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
          FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BIOBANKING PRODUCT PROVIDERS
    5.5 PRICING ANALYSIS 
           5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
                    TABLE 3 PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER
           5.5.2 AVERAGE SELLING PRICE TREND
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 23 VALUE CHAIN ANALYSIS OF MARKET
    5.7 SUPPLY CHAIN ANALYSIS 
          FIGURE 24 MARKET: SUPPLY CHAIN ANALYSIS
    5.8 ECOSYSTEM ANALYSIS 
          FIGURE 25 ECOSYSTEM ANALYSIS: MARKET
          TABLE 4 SUPPLY CHAIN ECOSYSTEM
    5.9 PATENT ANALYSIS 
          FIGURE 26 PATENT APPLICATIONS FOR MARKET, JANUARY 2013–APRIL 2023
    5.10 KEY CONFERENCES AND EVENTS IN 2023 
           TABLE 5 MARKET: LIST OF CONFERENCES AND EVENTS
    5.11 REGULATORY ANALYSIS 
           5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
    5.12 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 6 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF BUYERS
           5.12.4 BARGAINING POWER OF SUPPLIERS
           5.12.5 INTENSITY OF COMPETITIVE RIVALRY
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOBANKING PRODUCTS
           5.13.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS AMONG END USERS
                     FIGURE 28 KEY BUYING CRITERIA FOR END USERS
 
6 BIOBANKING MARKET, BY PRODUCT & SERVICE (Page No. - 72)
    6.1 INTRODUCTION 
          TABLE 7 MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
    6.2 EQUIPMENT 
          TABLE 8 BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 9 BIOBANKING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 10 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 11 EUROPE: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 12 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 13 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 STORAGE EQUIPMENT
                    6.2.1.1 Storage solutions for biobanking to ensure integrity and longevity of biological samples
                                TABLE 14 STORAGE EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 15 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 16 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 17 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 18 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 SAMPLE ANALYSIS EQUIPMENT
                    6.2.2.1 Ensures sample integrity, traceability, and preservation
                                TABLE 19 SAMPLE ANALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 20 NORTH AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 21 EUROPE: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 22 ASIA PACIFIC: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 23 LATIN AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 SAMPLE PROCESSING EQUIPMENT
                    6.2.3.1 Demand for reliable biobanking equipment to propel adoption
                                TABLE 24 SAMPLE PROCESSING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 25 NORTH AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 26 EUROPE: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 27 ASIA PACIFIC: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 28 LATIN AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 SAMPLE TRANSPORT EQUIPMENT
                    6.2.4.1 Need for reliable transport equipment to maintain sample integrity and quality to drive market
                                TABLE 29 SAMPLE TRANSPORT EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 30 NORTH AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 31 EUROPE: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 32 ASIA PACIFIC: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 33 LATIN AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 CONSUMABLES 
          TABLE 34 BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 35 BIOBANKING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 36 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 37 EUROPE: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 38 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 39 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 STORAGE CONSUMABLES
                    6.3.1.1 Play crucial role in preserving integrity and viability of samples
                                TABLE 40 STORAGE CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 41 NORTH AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 42 EUROPE: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 43 ASIA PACIFIC: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 LATIN AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 ANALYSIS CONSUMABLES
                    6.3.2.1 Increasing demand for sample analysis to fuel adoption
                                TABLE 45 ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 46 NORTH AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 47 EUROPE: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 48 ASIA PACIFIC: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 49 LATIN AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 PROCESSING CONSUMABLES
                    6.3.3.1 Use of sample processing consumables for efficient biobanking to drive growth
                                TABLE 50 PROCESSING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 51 NORTH AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 52 EUROPE: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 53 ASIA PACIFIC: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 LATIN AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 COLLECTION CONSUMABLES
                    6.3.4.1 Demand for efficient sample handling to drive adoption
                                TABLE 55 COLLECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 56 NORTH AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 57 EUROPE: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 58 ASIA PACIFIC: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 59 LATIN AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 SERVICES 
          TABLE 60 BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 61 BIOBANKING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 62 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 63 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 64 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 65 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.1 STORAGE SERVICES
                    6.4.1.1 Increasing number of biological samples to fuel demand for storage services
                                TABLE 66 STORAGE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 67 NORTH AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 68 EUROPE: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 69 ASIA PACIFIC: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 70 LATIN AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.2 PROCESSING SERVICES
                    6.4.2.1 Critical for preparation of samples for storage and analysis
                                TABLE 71 PROCESSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 72 NORTH AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 73 EUROPE: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 74 ASIA PACIFIC: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 75 LATIN AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.3 TRANSPORT SERVICES
                    6.4.3.1 Help in facilitating biobanking operations
                                TABLE 76 TRANSPORT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 77 NORTH AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 78 EUROPE: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 79 ASIA PACIFIC: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 80 LATIN AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.4 SUPPLY SERVICES
                    6.4.4.1 Supply services for biobanking to enable research and discovery
                                TABLE 81 SUPPLY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 82 NORTH AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 83 EUROPE: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 84 ASIA PACIFIC: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 85 LATIN AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 SOFTWARE 
           6.5.1 RISING ADOPTION OF BIOBANKING SOFTWARE TO MANAGE BIOLOGICAL SAMPLES TO DRIVE GROWTH
                    TABLE 86 BIOBANKING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 87 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 88 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 90 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 BIOBANKING MARKET, BY STORAGE TYPE (Page No. - 111)
    7.1 INTRODUCTION 
          TABLE 91 MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
    7.2 MANUAL STORAGE 
           7.2.1 POPULARITY OF MANUAL STORAGE OVER AUTOMATED STORAGE TO SUPPORT MARKET GROWTH
                    TABLE 92 MARKET FOR MANUAL STORAGE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 93 NORTH AMERICA: MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 94 EUROPE: MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 96 LATIN AMERICA: MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 AUTOMATED STORAGE 
           7.3.1 EFFICIENT TRACKING OF SAMPLES AND REDUCTION OF MANUAL ERRORS TO DRIVE MARKET
                    TABLE 97 MARKET FOR AUTOMATED STORAGE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 98 NORTH AMERICA: MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 EUROPE: MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 100 ASIA PACIFIC: MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 101 LATIN AMERICA: MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 BIOBANKING MARKET, BY SAMPLE TYPE (Page No. - 118)
    8.1 INTRODUCTION 
          TABLE 102 MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
    8.2 BLOOD PRODUCTS 
           8.2.1 USE IN WIDE RANGE OF APPLICATIONS TO PROPEL MARKET
                    TABLE 103 MARKET FOR BLOOD PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 104 NORTH AMERICA: MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 105 EUROPE: MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 106 ASIA PACIFIC: MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 107 LATIN AMERICA: MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 HUMAN TISSUES 
           8.3.1 PIVOTAL ROLE IN FACILITATING SCIENTIFIC DISCOVERIES AND IMPROVING PATIENT CARE TO DRIVE MARKET
                    TABLE 108 MARKET FOR HUMAN TISSUES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 109 NORTH AMERICA: MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 110 EUROPE: MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 111 ASIA PACIFIC: MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 112 LATIN AMERICA: MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 CELL LINES 
           8.4.1 SERVE AS VALUABLE RESOURCES IN BIOBANKING
                    TABLE 113 MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 114 NORTH AMERICA: MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 115 EUROPE: MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 116 ASIA PACIFIC: MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 117 LATIN AMERICA: MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 NUCLEIC ACIDS 
           8.5.1 GROWING DEMAND FOR STORAGE AND ANALYSIS OF NUCLEIC ACIDS TO DRIVE MARKET
                    TABLE 118 MARKET FOR NUCLEIC ACIDS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 119 NORTH AMERICA: MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 120 EUROPE: MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 121 ASIA PACIFIC: MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 122 LATIN AMERICA: MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 BIOLOGICAL FLUIDS 
           8.6.1 SERVE AS VALUABLE RESOURCES FOR RESEARCHERS AND CLINICIANS IN STUDYING DISEASES
                    TABLE 123 MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 124 NORTH AMERICA: MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 125 EUROPE: MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 126 ASIA PACIFIC: MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 127 LATIN AMERICA: MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.7 HUMAN WASTE PRODUCTS 
           8.7.1 USE OF HUMAN WASTE PRODUCT SAMPLES IN MICROBIOME RESEARCH TO DRIVE MARKET
                    TABLE 128 MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 129 NORTH AMERICA: MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 130 EUROPE: MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 131 ASIA PACIFIC: MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 132 LATIN AMERICA: MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 BIOBANKING MARKET, BY OWNERSHIP (Page No. - 136)
    9.1 INTRODUCTION 
           TABLE 133 MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
    9.2 UNIVERSITIES OWNED
           9.2.1 IMPORTANCE OF BIOBANKING IN ADVANCING RESEARCH TO DRIVE MARKET
                    TABLE 134 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 135 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 136 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 137 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 138 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 NATIONAL/REGIONAL AGENCIES OWNED
           9.3.1 SUSTAINED FUNDING AND STANDARDIZED PRACTICES TO SUPPORT MARKET GROWTH
                    TABLE 139 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 140 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 141 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 142 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 143 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 NON-PROFIT ORGANIZATIONS OWNED
           9.4.1 FOCUS OF NON-PROFIT ORGANIZATIONS ON ADVANCING RESEARCH TO DRIVE MARKET
                    TABLE 144 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 145 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 146 EUROPE: NMARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 147 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 148 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 PRIVATE ORGANIZATIONS OWNED
           9.5.1 INCREASING OWNERSHIP OF BIOBANKS BY PRIVATE ORGANIZATIONS TO DRIVE MARKET
                    TABLE 149 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 150 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 151 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 152 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 153 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 BIOBANKING MARKET, BY APPLICATION (Page No. - 148)
     10.1 INTRODUCTION 
             TABLE 154 MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
     10.2 REGENERATIVE MEDICINE 
             10.2.1 INCREASING RESEARCH AND RISING GOVERNMENT FUNDING TO DRIVE MARKET
                        TABLE 155 MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 156 NORTH AMERICA: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 157 EUROPE: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 158 ASIA PACIFIC: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 159 LATIN AMERICA: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 LIFE SCIENCE RESEARCH 
             10.3.1 INCREASING DEMAND AND UTILIZATION OF BIOBANKS IN LIFE SCIENCE RESEARCH APPLICATIONS TO SUPPORT MARKET GROWTH
                        FIGURE 29 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
                        TABLE 160 MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 161 NORTH AMERICA: MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 162 EUROPE: MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 163 ASIA PACIFIC: MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 164 LATIN AMERICA: MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 CLINICAL RESEARCH 
             10.4.1 GROWING FOCUS ON BIOMARKER DISCOVERY AND ACCELERATED DRUG DEVELOPMENT TO PROPEL MARKET
                        TABLE 165 MARKET FOR CLINICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 166 NORTH AMERICA: MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 167 EUROPE: MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 168 ASIA PACIFIC: MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 169 LATIN AMERICA: MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 BIOBANKING MARKET, BY END USER (Page No. - 158)
     11.1 INTRODUCTION 
             TABLE 170 MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS 
             11.2.1 LARGEST END USER SEGMENT DUE TO GROWING NUMBER OF CLINICAL TRIALS AND RESEARCH STUDIES
                        TABLE 171 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 172 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 173 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 174 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 175 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
     11.3 ACADEMIC AND RESEARCH INSTITUTES 
             11.3.1 ADVANCEMENTS IN SCIENTIFIC RESEARCH AND INNOVATION TO DRIVE MARKET
                        TABLE 176 MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 177 NORTH AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 178 EUROPE: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 179 ASIA PACIFIC: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 180 LATIN AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
     11.4 HOSPITALS 
             11.4.1 USE BIOBANKING TO COLLECT, STORE, AND MANAGE PATIENT SAMPLES FOR DIAGNOSTIC PURPOSES
                        TABLE 181 MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 182 NORTH AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 183 EUROPE: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 184 ASIA PACIFIC: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 185 LATIN AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
 
12 BIOBANKING MARKET, BY REGION (Page No. - 168)
     12.1 INTRODUCTION 
             TABLE 186 BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
     12.2 NORTH AMERICA 
             12.2.1 RECESSION IMPACT
                        FIGURE 30 NORTH AMERICA: BIOBANKING MARKET SNAPSHOT
                        TABLE 187 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 188 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 189 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 190 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 191 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 192 NORTH AMERICA: MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 193 NORTH AMERICA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 194 NORTH AMERICA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 195 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 196 NORTH AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.2 US
                        12.2.2.1 Largest market in North America due to surge in genomic research
                                      TABLE 197 US: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 198 US: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 199 US: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 200 US: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 201 US: MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 202 US: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 203 US: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 204 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 205 US: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.3 CANADA
                        12.2.3.1 Increasing number of biobanks to support market
                                      TABLE 206 CANADA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 207 CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 208 CANADA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 209 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 210 CANADA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 211 CANADA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 212 CANADA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 213 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 214 CANADA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
     12.3 EUROPE 
             12.3.1 RECESSION IMPACT
                        TABLE 215 EUROPE: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 216 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 217 EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 218 EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 219 EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 220 EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 221 EUROPE: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 222 EUROPE: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 223 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 224 EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.2 GERMANY
                        12.3.2.1 Largest market for biobanking in Europe
                                      TABLE 225 GERMANY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 226 GERMANY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 227 GERMANY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 228 GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 229 GERMANY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 230 GERMANY: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 231 GERMANY: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 232 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 233 GERMANY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.3 UK
                        12.3.3.1 Increasing number of biobanks to support market growth
                                      TABLE 234 UK: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 235 UK: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 236 UK: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 237 UK: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 238 UK: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 239 UK: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 240 UK: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 241 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 242 UK: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.4 FRANCE
                        12.3.4.1 Robust healthcare infrastructure and advanced research capabilities to propel market
                                      TABLE 243 FRANCE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 244 FRANCE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 245 FRANCE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 246 FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 247 FRANCE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 248 FRANCE: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 249 FRANCE: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 250 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 251 FRANCE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.5 ITALY
                        12.3.5.1 Emergence of private sector players to support market growth
                                      TABLE 252 ITALY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 253 ITALY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 254 ITALY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 255 ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 256 ITALY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 257 ITALY: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 258 ITALY: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 259 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 260 ITALY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.6 SPAIN
                        12.3.6.1 Favorable government initiatives to propel market
                                      TABLE 261 SPAIN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 262 SPAIN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 263 SPAIN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 264 SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 265 SPAIN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 266 SPAIN: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 267 SPAIN: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 268 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 269 SPAIN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.7 REST OF EUROPE
                        TABLE 270 REST OF EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 271 REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 272 REST OF EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 273 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 274 REST OF EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 275 REST OF EUROPE: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 276 REST OF EUROPE: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 277 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 278 REST OF EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
     12.4 ASIA PACIFIC 
             12.4.1 RECESSION IMPACT
                        FIGURE 31 ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT
                        TABLE 279 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 280 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 281 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 282 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 283 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 284 ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 285 ASIA PACIFIC: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 286 ASIA PACIFIC: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 287 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 288 ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.2 CHINA
                        12.4.2.1 Advanced healthcare infrastructure and increasing investments in medical research to propel market
                                      TABLE 289 CHINA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 290 CHINA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 291 CHINA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 292 CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 293 CHINA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 294 CHINA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 295 CHINA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 296 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 297 CHINA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.3 JAPAN
                        12.4.3.1 Advancements in medical research and increasing need for personalized medicine to drive market
                                      TABLE 298 JAPAN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 299 JAPAN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 300 JAPAN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 301 JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 302 JAPAN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 303 JAPAN: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 304 JAPAN: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 305 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 306 JAPAN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.4 INDIA
                        12.4.4.1 Demand for high-quality biological samples for medical research and development to drive market
                                      TABLE 307 INDIA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 308 INDIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 309 INDIA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 310 INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 311 INDIA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 312 INDIA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 313 INDIA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 314 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 315 INDIA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.5 REST OF ASIA PACIFIC
                        TABLE 316 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 317 REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 318 REST OF ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 319 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 320 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 321 REST OF ASIA PACIFIC: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 322 REST OF ASIA PACIFIC: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 323 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 324 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
     12.5 LATIN AMERICA 
             12.5.1 RECESSION IMPACT
                        TABLE 325 LATIN AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 326 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 327 LATIN AMERICA BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 328 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 329 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 330 LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 331 LATIN AMERICA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 332 LATIN AMERICA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 333 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 334 LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.5.2 BRAZIL
                        12.5.2.1 Advancements in research capabilities to favor market growth
                                      TABLE 335 BRAZIL: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 336 BRAZIL: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 337 BRAZIL: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 338 BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 339 BRAZIL: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 340 BRAZIL: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                                      TABLE 341 BRAZIL: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                                      TABLE 342 BRAZIL: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 343 BRAZIL: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.5.3 REST OF LATIN AMERICA
                        TABLE 344 REST OF LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 345 REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 346 REST OF LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 347 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 348 REST OF LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 349 REST OF LATIN AMERICA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 350 REST OF LATIN AMERICA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 351 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 352 REST OF LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
     12.6 MIDDLE EAST & AFRICA 
             12.6.1 INCREASING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET
             12.6.2 RECESSION IMPACT
                        TABLE 353 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 354 MIDDLE EAST & AFRICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 355 MIDDLE EAST & AFRICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 356 MIDDLE EAST & AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 357 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
                        TABLE 358 MIDDLE EAST & AFRICA: MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
                        TABLE 359 MIDDLE EAST & AFRICA: MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
                        TABLE 360 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 361 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
 
13 COMPETITIVE LANDSCAPE (Page No. - 244)
     13.1 OVERVIEW 
     13.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 32 KEY PLAYER STRATEGIES IN BIOBANKING MARKET, JANUARY 2020–APRIL 2023
     13.3 MARKET SHARE ANALYSIS 
             FIGURE 33 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
             TABLE 362 MARKET: DEGREE OF COMPETITION
     13.4 REVENUE SHARE ANALYSIS 
             FIGURE 34 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
     13.5 COMPANY EVALUATION QUADRANT 
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
                        FIGURE 35 MARKET: COMPANY EVALUATION QUADRANT, 2022
     13.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 STARTING BLOCKS
             13.6.3 RESPONSIVE COMPANIES
             13.6.4 DYNAMIC COMPANIES
                        FIGURE 36 MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2022
             13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
                        TABLE 363 MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                        TABLE 364 MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
     13.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             13.7.1 COMPANY FOOTPRINT ANALYSIS
                        TABLE 365 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS
             13.7.2 END USER FOOTPRINT ANALYSIS
                        TABLE 366 END USER FOOTPRINT ANALYSIS OF KEY PLAYERS
             13.7.3 REGIONAL FOOTPRINT ANALYSIS
                        TABLE 367 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
     13.8 COMPETITIVE SCENARIO AND TRENDS 
             TABLE 368 MARKET: DEALS, JANUARY 2020–APRIL 2023
             TABLE 369 MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020–APRIL 2023
             TABLE 370 BIOBANKING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023
 
14 COMPANY PROFILES (Page No. - 258)
     14.1 KEY PLAYERS 
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
             14.1.1 THERMO FISHER SCIENTIFIC INC.
                        TABLE 371 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                        FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
             14.1.2 PHC HOLDINGS CORPORATION
                        TABLE 372 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
                        FIGURE 38 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
             14.1.3 BECTON, DICKINSON AND COMPANY
                        TABLE 373 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
             14.1.4 QIAGEN N.V.
                        TABLE 374 QIAGEN N.V.: COMPANY OVERVIEW
                        FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
             14.1.5 MERCK KGAA
                        TABLE 375 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
             14.1.6 AVANTOR, INC
                        TABLE 376 AVANTOR, INC.: COMPANY OVERVIEW
                        FIGURE 42 AVANTOR, INC.: COMPANY SNAPSHOT (2022)
             14.1.7 CRYOPORT, INC.
                        TABLE 377 CRYOPORT, INC.: COMPANY OVERVIEW
                        FIGURE 43 CRYOPORT, INC.: COMPANY SNAPSHOT (2022)
             14.1.8 TECAN TRADING AG
                        TABLE 378 TECAN TRADING AG: COMPANY OVERVIEW
                        FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
             14.1.9 AZENTA, INC.
                        TABLE 379 AZENTA, INC.: COMPANY OVERVIEW
                        FIGURE 45 AZENTA, INC.: COMPANY SNAPSHOT (2022)
             14.1.10 GREINER AG
                        TABLE 380 GREINER AG: COMPANY OVERVIEW
                        FIGURE 46 GREINER AG: COMPANY SNAPSHOT (2021)
     14.2 OTHER PLAYERS 
             14.2.1 HAMILTON COMPANY
             14.2.2 MICRONIC
             14.2.3 AMSBIO
             14.2.4 BAY BIOSCIENCES LLC
             14.2.5 BIOKRYO
             14.2.6 SPT LABTECH
             14.2.7 ASKION GMBH
             14.2.8 CELL&CO BIOSERVICES
             14.2.9 ZIATH LTD.
             14.2.10 CTIBIOTECH
             14.2.11 CURELINE
             14.2.12 FIRALIS GROUP
             14.2.13 SOPACHEM
             14.2.14 PROTEOGENEX
             14.2.15 US BIOLAB CORPORATION, INC.
 
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
 
15 APPENDIX (Page No. - 317)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global biobanking market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as the World Health Organization (WHO), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), International Society for Biological and Environmental Repositories (ISBER), BBMRI-ERIC, European, Middle Eastern & African Society for Biopreservation and Biobanking (ESBB), Nature Journal, Genome Medicine, Mary Ann Liebert, Inc., PubMed, Government Associations. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global biobanking market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global biobanking market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, food and beverage companies, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Biobanking Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the biobanking market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the biobanking business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Biobanking is the process in which body fluid samples and tissues are collected for life science research. This process is carried out in biobanks, which store the samples for long-term use. Biobanking supports medical research activities by providing various services, which include sample processing, storage, and distribution of biological samples such as blood, urine, human tissues, and cell lines.

Stakeholders

  • Manufacturers, Vendors, and Distributors
  • Academic and Government Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Research & Development (R&D) Companies
  • Contract Research Organizations (CROs)
  • Market Research and Consulting Firms

Report Objectives

  • To define, describe, and forecast the global biobanking market based on product & service, storage type, sample type, ownership, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product/ service launches, expansions, agreements, partnerships, and collaborations in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 1224
Published ON
May, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biobanking Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback